New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state
RADNOR, PA – April 15, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 miles from downtown Philadelphia and will be close to the company’s legacy office in Blue Bell, Pennsylvania, which has been open since 2018.
Certara has 120 employees based in Pennsylvania and plans to hire more regional talent to support its expanding business. Gaining recognition as a prosperous life sciences community, the greater Philadelphia region was recently designated by the U.S. Department of Commerce’s Economic Development Administration as one of the nation’s inaugural Precision Medicine Tech Hubs. The area is primed for technology innovation and job creation, and well positioned to rapidly advance life science research and precision medicine initiatives.
“We are excited to move our headquarters to Radnor, a vibrant and dynamic community that offers a collaborative and engaging environment for our employees and clients,” said Dr. William F. Feehery, CEO of Certara. “We are honored to continue to play a role in the life science innovation driven by companies across this great state.”
To celebrate the new headquarters, Certara will host a ribbon-cutting ceremony and a grand opening luncheon on Monday, May 20th. The event will feature remarks from Dr. Feehery and other distinguished guests about the company’s vision and a tour of the new office space. The building features a range of amenities, including a fitness facility, large training rooms, and electric car charging stations.
Certara’s new headquarters is located at 4 Radnor Corporate Center, Suite 350, Radnor, PA 19087. The company also has offices across the U.S., Canada, U.K., France, Germany, Switzerland, India, Japan, and China. Certara holds numerous global workplace excellence awards including Fortune’s Best Workplaces in BioPharma™ 2023 and 2023-2024 certified Great Place to Work®. To learn more about Certara’s current career opportunities in Pennsylvania and around the world, visit careers.certara.com.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. The company offers a comprehensive model-informed drug development approach at scale to improve research and development productivity. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com and follow Certara on LinkedIn.
Certara Contact:
Sheila Rocchio
Media Contact:
Alyssa Horowitz